Xiangyu Jin

Vice President - Clinical Development

Dr. Jin has over 6 years of experience in pre market clinical development of innovative drugs and 19 years of  physician experience in oncology. She graduated from the Department of Clinical Medicine at Zhejiang University and later became an oncologist at Zhejiang Cancer Hospital, working for 19 years. During this period, she participated in dozens of global and domestic phase I, II, III, and IV clinical trials, and established a phase I clinical trial ward. She left the hospital and entered the industrial sector in 2019. In 2019, she joined Hangzhou DAC Biotechnology Co., Ltd. as the Chief Medical Officer, established the Clinical Medicine Department, and led pre market research for all products of the company. In 2021, she joined Betta Pharmaceutical Co., Ltd. as Senior Medical Director, leading the medical team and clinical operations team, responsible for around 20 clinical trials from Phase I to Phase III. During this period, three anti-tumor small molecules were granted market approval.